Peptide CDMO Market Analysis: Emerging Technologies and Forecast
The future outlook for the Peptide CDMO Market remains positive as peptide-based therapeutics gain greater attention from pharmaceutical and biotechnology developers. WiseGuyReports forecasts the market to expand from USD 10.29 billion in 2024 to USD 27.2 billion by 2032, supported by a reported CAGR of 12.93%. Growing demand for peptide therapies, technological progress, and increasing...
0 Comments 0 Shares 20 Views 0 Reviews